CLU and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), HSF1 upregulates PD-L1 expression through inducing apolipoprotein J (APOJ) expression and activating the STAT3 signaling pathway to neutralize the cytotoxic effects of CD8+ T cell against cancer cells (Fig. 3A) 107.